Estudos Clínicos de HCC

Três grandes RCTs estão investigando o uso das microsferas de resina SIR-Spheres® Y-90 no tratamento de Carcinoma Hepatocelular (Hepatocellular Carcinoma – HCC).

Os estudos SARAH e SIRveNIB comparam a eficácia e segurança das microsferas de resina SIR-Spheres Y-90 versus sorafenib, enquanto o estudo SORAMIC compara o tratamento de HCC com microsferas de resina SIR-Spheres Y-90 seguidas pelo sorafenib versus sorafenib somente.

As microsferas de resina SIR-Spheres Y-90 foram extensivamente usadas no tratamento de HCC. Foram publicados diversos estudos prospectivos e retrospectivos sobre as microsferas de resina SIR-Spheres Y-90 em terapias de primeira linha ou segunda linha em diferentes estágios da doença. Consulte resumo dos dados publicados para as microesferas de resina SIR-Spheres Y-90 no tratamento de HCC.

Now leaving

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.



You are now leaving your current region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.